25 XP   0   0   10

Grifols SA ADR
Buy, Hold or Sell?

Let's analyse Grifols together

PenkeI guess you are interested in Grifols SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Grifols SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.

Quick analysis of Grifols (30 sec.)










What can you expect buying and holding a share of Grifols? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
$11.76
Expected worth in 1 year
$4.97
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$-6.79
Return On Investment
-102.1%

For what price can you sell your share?

Current Price per Share
$6.65
Expected price per share
$5.3001 - $12.15
How sure are you?
50%

1. Valuation of Grifols (5 min.)




Live pricePrice per Share (EOD)

$6.65

Intrinsic Value Per Share

$-6.80 - $1.16

Total Value Per Share

$4.96 - $12.92

2. Growth of Grifols (5 min.)




Is Grifols growing?

Current yearPrevious yearGrowGrow %
How rich?$7.9b$9.1b-$1.1b-14.6%

How much money is Grifols making?

Current yearPrevious yearGrowGrow %
Making money$64.1m$225.2m-$161.1m-251.1%
Net Profit Margin0.9%3.4%--

How much money comes from the company's main activities?

3. Financial Health of Grifols (5 min.)




What can you expect buying and holding a share of Grifols? (5 min.)

Welcome investor! Grifols's management wants to use your money to grow the business. In return you get a share of Grifols.

What can you expect buying and holding a share of Grifols?

First you should know what it really means to hold a share of Grifols. And how you can make/lose money.

Speculation

The Price per Share of Grifols is $6.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Grifols.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Grifols, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $11.76. Based on the TTM, the Book Value Change Per Share is $-1.70 per quarter. Based on the YOY, the Book Value Change Per Share is $0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Grifols.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.091.4%0.091.4%0.335.0%0.548.1%0.7311.0%
Usd Book Value Change Per Share-1.70-25.5%-1.70-25.5%0.537.9%0.9814.7%0.8713.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.192.9%0.274.0%
Usd Total Gains Per Share-1.70-25.5%-1.70-25.5%0.537.9%1.1717.6%1.1417.1%
Usd Price Per Share11.56-11.56-8.50-14.60-19.68-
Price to Earnings Ratio122.35-122.35-25.65-45.84-36.26-
Price-to-Total Gains Ratio-6.81--6.81-16.09--345.96--153.53-
Price to Book Ratio0.98-0.98-0.63-1.34-3.21-
Price-to-Total Gains Ratio-6.81--6.81-16.09--345.96--153.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.65
Number of shares150
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.19
Usd Book Value Change Per Share-1.700.98
Usd Total Gains Per Share-1.701.17
Gains per Quarter (150 shares)-254.60176.06
Gains per Year (150 shares)-1,018.39704.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1018-1028116588694
20-2037-204623211761398
30-3055-306434817642102
40-4074-408246423522806
50-5092-510058129413510
60-6110-611869735294214
70-7129-713681341174918
80-8147-815492947055622
90-9166-9172104552936326
100-10184-10190116158817030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%16.03.00.084.2%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%17.00.02.089.5%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%17.02.00.089.5%

Fundamentals of Grifols

About Grifols SA ADR

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factorVIII/von Willerbrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It markets diagnostic testing equipment, reagents, and other equipment; biological products; manufactures and sells plasma to third parties; and involves in research activities, as well as markets pharmaceutical products for hospital pharmacies. In addition, the company offers Yimmugo PID, an immunology drug; and Yimmugo ITP, a hematology drug. Further, it develops Xembify Pre-filled syringes, FlexBag, and Prolastin vials; Xembify Biweekly dosing, Prolastin-C, Fostamatinib2, and VISTASEAL which are in Phase IV development stage; Xembify, Albumin 20% and 5%, Fibrinogen, Trimodulin, Cytotec pregnancy, and AMBAR-Next in Phase III development stage; and AKST4290 that is in Phase II clinical development. Additionally, it offers recIG, Alpha-1 AT in non-cystic fibrosis bronchiectasis, ATIII, GIGA 2339, GIGA564, and OSIG. It has collaboration agreements with Canadian Blood Services for the processing of other plasma-derived products and with GIANT; and GigaGen to develop recombinant polyclonal immunoglobulin therapies. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2024-03-20 19:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Grifols SA ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Grifols earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 0.9% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Grifols SA ADR:

  • The MRQ is 0.9%. The company is not making a profit/loss.
  • The TTM is 0.9%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.9%0.0%
TTM0.9%YOY3.4%-2.5%
TTM0.9%5Y6.7%-5.8%
5Y6.7%10Y10.3%-3.6%
1.1.2. Return on Assets

Shows how efficient Grifols is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • 0.3% Return on Assets means that Grifols generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Grifols SA ADR:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY1.0%-0.7%
TTM0.3%5Y2.3%-2.0%
5Y2.3%10Y4.1%-1.8%
1.1.3. Return on Equity

Shows how efficient Grifols is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • 1.1% Return on Equity means Grifols generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Grifols SA ADR:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.1%0.0%
TTM1.1%YOY3.4%-2.3%
TTM1.1%5Y7.2%-6.1%
5Y7.2%10Y12.3%-5.2%

1.2. Operating Efficiency of Grifols SA ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Grifols is operating .

  • Measures how much profit Grifols makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 11.2% means the company generated $0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Grifols SA ADR:

  • The MRQ is 11.2%. The company is operating less efficient.
  • The TTM is 11.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.2%TTM11.2%0.0%
TTM11.2%YOY13.3%-2.1%
TTM11.2%5Y15.5%-4.3%
5Y15.5%10Y19.4%-4.0%
1.2.2. Operating Ratio

Measures how efficient Grifols is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are $0.89 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Grifols SA ADR:

  • The MRQ is 0.888. The company is less efficient in keeping operating costs low.
  • The TTM is 0.888. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.888TTM0.8880.000
TTM0.888YOY0.884+0.004
TTM0.8885Y0.851+0.037
5Y0.85110Y0.807+0.044

1.3. Liquidity of Grifols SA ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Grifols is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.79 means the company has $2.79 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Grifols SA ADR:

  • The MRQ is 2.786. The company is able to pay all its short-term debts. +1
  • The TTM is 2.786. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.786TTM2.7860.000
TTM2.786YOY2.379+0.407
TTM2.7865Y2.609+0.177
5Y2.60910Y2.737-0.128
1.3.2. Quick Ratio

Measures if Grifols is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.58 means the company can pay off $0.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Grifols SA ADR:

  • The MRQ is 0.579. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.579. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.579TTM0.5790.000
TTM0.579YOY0.710-0.131
TTM0.5795Y1.406-0.828
5Y1.40610Y1.391+0.015

1.4. Solvency of Grifols SA ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Grifols assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Grifols to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.63 means that Grifols assets are financed with 62.8% credit (debt) and the remaining percentage (100% - 62.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Grifols SA ADR:

  • The MRQ is 0.628. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.628. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.628TTM0.6280.000
TTM0.628YOY0.607+0.021
TTM0.6285Y0.586+0.042
5Y0.58610Y0.619-0.033
1.4.2. Debt to Equity Ratio

Measures if Grifols is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Grifols to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 231.1% means that company has $2.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Grifols SA ADR:

  • The MRQ is 2.311. The company is just not able to pay all its debts with equity.
  • The TTM is 2.311. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.311TTM2.3110.000
TTM2.311YOY2.133+0.178
TTM2.3115Y1.948+0.363
5Y1.94810Y1.940+0.008

2. Market Valuation of Grifols SA ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Grifols generates.

  • Above 15 is considered overpriced but always compare Grifols to the Drug Manufacturers - General industry mean.
  • A PE ratio of 122.35 means the investor is paying $122.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Grifols SA ADR:

  • The EOD is 70.385. Based on the earnings, the company is expensive. -2
  • The MRQ is 122.353. Based on the earnings, the company is expensive. -2
  • The TTM is 122.353. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD70.385MRQ122.353-51.968
MRQ122.353TTM122.3530.000
TTM122.353YOY25.648+96.705
TTM122.3535Y45.840+76.514
5Y45.84010Y36.257+9.583
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Grifols SA ADR:

  • The EOD is -47.912. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -83.287. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -83.287. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-47.912MRQ-83.287+35.375
MRQ-83.287TTM-83.2870.000
TTM-83.287YOY-13.824-69.463
TTM-83.2875Y7.560-90.847
5Y7.56010Y27.977-20.418
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Grifols is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.98 means the investor is paying $0.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Grifols SA ADR:

  • The EOD is 0.565. Based on the equity, the company is cheap. +2
  • The MRQ is 0.983. Based on the equity, the company is cheap. +2
  • The TTM is 0.983. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.565MRQ0.983-0.418
MRQ0.983TTM0.9830.000
TTM0.983YOY0.632+0.351
TTM0.9835Y1.339-0.356
5Y1.33910Y3.211-1.872
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Grifols SA ADR.

3.1. Institutions holding Grifols SA ADR

Institutions are holding 49.739% of the shares of Grifols SA ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Capital World Investors2.91380.0407197875251584740.8073
2023-12-31Millennium Management LLC2.31770.078715739163184272613.2604
2023-12-31Brandes Investment Partners & Co1.99032.37213516011245473022.1921
2023-12-31Black Creek Investment Management Inc1.36243.50599251618-322770-3.3712
2023-12-31Flat Footed LLC1.08369.11767358779-1941520-20.8759
2023-12-31Pictet Asset Manangement SA1.05520.091471656733340994.8905
2023-12-31First Trust Advisors L.P.0.68990.059146847493023806.8999
2023-12-31Capital Research Global Investors0.63780.0123433122200
2023-12-31Bank of America Corp0.61960.00494207933131989445.7021
2023-12-31Whitebox Advisors, LLC0.54161.16533678262171215687.0836
2023-09-30Point72 Asset Management, L.P.0.51920.0943525975161727584.7318
2023-12-31Morgan Stanley - Brokerage Accounts0.44020.0031298914584828039.6232
2023-12-31Harris Associates L.P.0.40590.05492756200-10200-0.3687
2023-12-31NORGES BANK0.33290.0046226094400
2023-12-31BlackRock Inc0.3040.00062064762527282.6206
2023-12-31New York State Common Retirement Fund0.30310.0329205828657243938.5261
2023-12-31SEI Investments Co0.29490.03722002416-402-0.0201
2023-12-31JPMorgan Chase & Co0.27890.0021189377952516238.3717
2023-12-31Fidelity International Ltd0.26990.02231832740-2709286-59.6493
2023-12-31HHG PLC0.26760.01251817474-430354-19.1453
Total 16.628516.7121112922656+6325811+5.6%

3.2. Funds holding Grifols SA ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds New Perspective A1.97030.12211338041200
2023-12-31Capital Group New Perspective Comp1.97030.12211338041200
2023-12-31American Funds Intl Gr and Inc F20.58860.30673997237-1378-0.0345
2023-12-31Capital Group Intl Growth & Inc Comp0.58860.30673997237-1378-0.0345
2023-06-30Azvalor Internacional FI0.56661.91183847545121983046.4217
2023-12-31Capital Group EuroPacific Growth Comp0.50090.029340142400
2023-12-31American Funds Europacific Growth A0.50090.029340142400
2023-06-30CI International Equity Fund F0.45934.1547311902200
2023-09-30United International Eq Alpha Corp Cl A0.37854.221257051700
2023-10-13Pictet Biopharmaceutical Mother0.3321.3448225450066370141.7212
2023-12-31Oakmark International Small Cap Investor0.26641.4377180900000
2023-12-31Black Creek International Equity CIT A0.25924.9163176054000
2024-02-29iShares Biotechnology ETF0.21190.14211439182-6475-0.4479
2024-01-31Fidelity European Growth A-Dis-EUR0.19810.154613453481080.008
2023-10-31Pictet-Global Megatrend Sel I USD0.17810.0919120952019400.1607
2024-01-31Brandes International Small Cap Eq0.15541.8871055008825058.4838
2023-12-31Brandes International Small Cap Equity A0.12582.3241853973399244.9044
2023-12-31American Funds IS® International 10.11690.127879369000
2023-12-31Capital Group International Composite0.11690.127879369000
2024-02-29Brandes Global Small Cap Equity Cl F0.11231.7254762611-11385-1.4709
Total 9.59725.482665172292+1987392+3.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Grifols SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.697-1.6970%0.527-422%0.980-273%0.867-296%
Book Value Per Share--11.76011.7600%13.458-13%11.589+1%8.426+40%
Current Ratio--2.7862.7860%2.379+17%2.609+7%2.737+2%
Debt To Asset Ratio--0.6280.6280%0.607+3%0.586+7%0.619+1%
Debt To Equity Ratio--2.3112.3110%2.133+8%1.948+19%1.940+19%
Dividend Per Share----0%0.001-100%0.194-100%0.269-100%
Eps--0.0940.0940%0.331-71%0.536-82%0.734-87%
Free Cash Flow Per Share---0.139-0.1390%-0.615+343%0.224-162%0.440-132%
Free Cash Flow To Equity Per Share--0.1580.1580%-0.891+666%0.479-67%0.874-82%
Gross Profit Margin--1.0001.0000%1.0000%0.698+43%0.162+518%
Intrinsic Value_10Y_max--1.165--------
Intrinsic Value_10Y_min---6.796--------
Intrinsic Value_1Y_max--0.371--------
Intrinsic Value_1Y_min---0.251--------
Intrinsic Value_3Y_max--0.921--------
Intrinsic Value_3Y_min---1.130--------
Intrinsic Value_5Y_max--1.238--------
Intrinsic Value_5Y_min---2.416--------
Market Cap4515961587.200-74%7850306745.2407850306745.2400%5778343707.000+36%9975958584.158-21%13463877864.216-42%
Net Profit Margin--0.0090.0090%0.034-74%0.067-87%0.103-91%
Operating Margin--0.1120.1120%0.133-16%0.155-28%0.194-42%
Operating Ratio--0.8880.8880%0.884+0%0.851+4%0.807+10%
Pb Ratio0.565-74%0.9830.9830%0.632+56%1.339-27%3.211-69%
Pe Ratio70.385-74%122.353122.3530%25.648+377%45.840+167%36.257+237%
Price Per Share6.650-74%11.56011.5600%8.500+36%14.604-21%19.676-41%
Price To Free Cash Flow Ratio-47.912+42%-83.287-83.2870%-13.824-83%7.560-1202%27.977-398%
Price To Total Gains Ratio-3.918+42%-6.811-6.8110%16.088-142%-345.959+4980%-153.531+2154%
Quick Ratio--0.5790.5790%0.710-19%1.406-59%1.391-58%
Return On Assets--0.0030.0030%0.010-69%0.023-87%0.041-93%
Return On Equity--0.0110.0110%0.034-68%0.072-85%0.123-91%
Total Gains Per Share---1.697-1.6970%0.528-421%1.174-245%1.136-249%
Usd Book Value--7986292000.0007986292000.0000%9148525344.800-13%7902657620.860+1%5753611310.430+39%
Usd Book Value Change Per Share---1.697-1.6970%0.527-422%0.980-273%0.867-296%
Usd Book Value Per Share--11.76011.7600%13.458-13%11.589+1%8.426+40%
Usd Dividend Per Share----0%0.001-100%0.194-100%0.269-100%
Usd Eps--0.0940.0940%0.331-71%0.536-82%0.734-87%
Usd Free Cash Flow---94256092.900-94256092.9000%-417998085.900+343%154191359.180-161%301733832.970-131%
Usd Free Cash Flow Per Share---0.139-0.1390%-0.615+343%0.224-162%0.440-132%
Usd Free Cash Flow To Equity Per Share--0.1580.1580%-0.891+666%0.479-67%0.874-82%
Usd Market Cap4515961587.200-74%7850306745.2407850306745.2400%5778343707.000+36%9975958584.158-21%13463877864.216-42%
Usd Price Per Share6.650-74%11.56011.5600%8.500+36%14.604-21%19.676-41%
Usd Profit--64161035.50064161035.5000%225295394.300-72%384352456.420-83%495830619.530-87%
Usd Revenue--7130541520.9007130541520.9000%6559393103.900+9%6063532304.940+18%5210804722.050+37%
Usd Total Gains Per Share---1.697-1.6970%0.528-421%1.174-245%1.136-249%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+10 -2610Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of Grifols SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1570.385
Price to Book Ratio (EOD)Between0-10.565
Net Profit Margin (MRQ)Greater than00.009
Operating Margin (MRQ)Greater than00.112
Quick Ratio (MRQ)Greater than10.579
Current Ratio (MRQ)Greater than12.786
Debt to Asset Ratio (MRQ)Less than10.628
Debt to Equity Ratio (MRQ)Less than12.311
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.079
Ma 20Greater thanMa 506.382
Ma 50Greater thanMa 1007.467
Ma 100Greater thanMa 2008.636
OpenGreater thanClose6.520
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Stockholders Equity  -49,5845,850-43,734-133,869-177,6032,130-175,473933,453757,980



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets21,454,670
Total Liabilities13,468,378
Total Stockholder Equity5,827,166
 As reported
Total Liabilities 13,468,378
Total Stockholder Equity+ 5,827,166
Total Assets = 21,454,670

Assets

Total Assets21,454,670
Total Current Assets6,451,905
Long-term Assets15,002,765
Total Current Assets
Cash And Cash Equivalents 529,577
Net Receivables 810,860
Inventory 3,459,277
Other Current Assets 1,652,191
Total Current Assets  (as reported)6,451,905
Total Current Assets  (calculated)6,451,905
+/-0
Long-term Assets
Property Plant Equipment 4,192,363
Goodwill 6,802,127
Long-term Assets Other 2,986,590
Long-term Assets  (as reported)15,002,765
Long-term Assets  (calculated)13,981,080
+/- 1,021,685

Liabilities & Shareholders' Equity

Total Current Liabilities2,315,604
Long-term Liabilities11,152,774
Total Stockholder Equity5,827,166
Total Current Liabilities
Short-term Debt 897,915
Accounts payable 813,114
Other Current Liabilities 565,382
Total Current Liabilities  (as reported)2,315,604
Total Current Liabilities  (calculated)2,276,411
+/- 39,193
Long-term Liabilities
Long-term Liabilities  (as reported)11,152,774
Long-term Liabilities  (calculated)0
+/- 11,152,774
Total Stockholder Equity
Common Stock119,604
Accumulated Other Comprehensive Income 4,949,582
Other Stockholders Equity 757,980
Total Stockholder Equity (as reported)5,827,166
Total Stockholder Equity (calculated)5,827,166
+/-0
Other
Cash and Short Term Investments 529,577
Common Stock Shares Outstanding 679,092
Current Deferred Revenue39,193
Liabilities and Stockholders Equity 21,454,670
Net Debt 9,587,862
Short Long Term Debt Total 10,117,439



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
821,683
913,674
939,569
1,180,239
1,657,177
1,888,982
5,807,718
5,627,474
5,841,036
8,449,749
9,601,715
10,129,772
10,920,264
12,477,046
15,542,611
15,274,776
19,233,835
21,533,977
21,454,670
21,454,67021,533,97719,233,83515,274,77615,542,61112,477,04610,920,26410,129,7729,601,7158,449,7495,841,0365,627,4745,807,7181,888,9821,657,1771,180,239939,569913,674821,683
   > Total Current Assets 
436,294
473,294
495,527
626,600
1,004,578
1,144,082
1,929,215
1,934,564
2,139,660
2,913,122
3,089,472
3,122,514
2,945,316
3,483,251
5,362,184
3,164,954
5,510,280
4,653,587
6,451,905
6,451,9054,653,5875,510,2803,164,9545,362,1843,483,2512,945,3163,122,5143,089,4722,913,1222,139,6601,934,5641,929,2151,144,0821,004,578626,600495,527473,294436,294
       Cash And Cash Equivalents 
22,856
26,883
5,690
6,368
249,372
239,649
340,586
473,327
708,777
1,079,146
1,142,500
895,009
886,521
1,033,792
741,982
579,647
655,493
547,979
529,577
529,577547,979655,493579,647741,9821,033,792886,521895,0091,142,5001,079,146708,777473,327340,586239,649249,3726,3685,69026,88322,856
       Short-term Investments 
661
6,232
7,080
6,657
8,217
12,946
16,904
2,585,988
232
476
553
1,499
4,380
3,241
1,727,429
10,861
2,029,107
43,256
0
043,2562,029,10710,8611,727,4293,2414,3801,4995534762322,585,98816,90412,9468,2176,6577,0806,232661
       Net Receivables 
147,710
188,868
200,472
231,806
255,182
282,994
531,989
447,441
462,655
608,328
477,803
528,518
385,265
401,573
470,495
504,200
495,476
754,820
810,860
810,860754,820495,476504,200470,495401,573385,265528,518477,803608,328462,655447,441531,989282,994255,182231,806200,472188,868147,710
       Inventory 
249,545
235,475
270,659
373,098
484,462
527,865
1,030,341
998,644
946,913
1,194,057
1,431,391
1,642,931
1,629,293
1,949,360
2,342,590
2,002,281
2,259,354
3,201,357
3,459,277
3,459,2773,201,3572,259,3542,002,2812,342,5901,949,3601,629,2931,642,9311,431,3911,194,057946,913998,6441,030,341527,865484,462373,098270,659235,475249,545
       Other Current Assets 
8,186
7,706
11,626
8,671
7,345
80,628
9,395
20,805
21,315
23,669
31,091
48,324
32,354
42,344
58,111
51,750
64,079
81,814
1,652,191
1,652,19181,81464,07951,75058,11142,34432,35448,32431,09123,66921,31520,8059,39580,6287,3458,67111,6267,7068,186
   > Long-term Assets 
385,389
440,380
444,042
553,639
652,599
744,900
3,878,503
3,692,910
3,701,376
5,536,627
6,512,243
7,007,258
7,974,948
8,993,795
10,180,427
12,109,822
13,723,555
16,880,390
15,002,765
15,002,76516,880,39013,723,55512,109,82210,180,4278,993,7957,974,9487,007,2586,512,2435,536,6273,701,3763,692,9103,878,503744,900652,599553,639444,042440,380385,389
       Property Plant Equipment 
186,621
184,993
201,332
301,009
371,705
434,131
775,869
810,107
840,238
1,147,782
1,644,402
1,809,852
1,760,053
1,951,983
2,863,403
3,002,803
3,343,154
4,168,489
4,192,363
4,192,3634,168,4893,343,1543,002,8032,863,4031,951,9831,760,0531,809,8521,644,4021,147,782840,238810,107775,869434,131371,705301,009201,332184,993186,621
       Goodwill 
117,115
150,820
150,243
158,567
174,000
189,448
1,895,101
1,869,899
1,829,141
3,174,732
3,532,359
3,643,995
4,590,498
5,209,230
5,507,063
5,332,271
6,228,901
7,011,909
6,802,127
6,802,1277,011,9096,228,9015,332,2715,507,0635,209,2304,590,4983,643,9953,532,3593,174,7321,829,1411,869,8991,895,101189,448174,000158,567150,243150,820117,115
       Long Term Investments 
0
0
0
0
0
0
0
0
39,130
58,651
84,858
232,421
259,063
228,820
143,984
2,067,177
2,359,975
2,548,892
0
02,548,8922,359,9752,067,177143,984228,820259,063232,42184,85858,65139,13000000000
       Intangible Assets 
48,718
60,850
57,223
57,756
69,385
78,299
1,008,307
969,095
946,435
1,068,361
1,161,572
1,195,302
1,269,342
1,385,537
1,433,534
1,557,650
1,636,950
2,949,147
0
02,949,1471,636,9501,557,6501,433,5341,385,5371,269,3421,195,3021,161,5721,068,361946,435969,0951,008,30778,29969,38557,75657,22360,85048,718
       Other Assets 
0
0
0
0
53,209
56,292
257,156
47,236
61,778
110,671
153,030
156,107
328,337
3,429,286
3,633,258
149,921
882,614
1,930,408
0
01,930,408882,614149,9213,633,2583,429,286328,337156,107153,030110,67161,77847,236257,15656,29253,2090000
> Total Liabilities 
765,736
545,322
555,403
698,960
1,078,649
1,181,592
4,142,724
3,746,733
3,733,832
5,786,861
6,300,325
6,401,794
7,286,299
7,780,442
8,696,843
8,554,721
11,086,800
13,076,433
13,468,378
13,468,37813,076,43311,086,8008,554,7218,696,8437,780,4427,286,2996,401,7946,300,3255,786,8613,733,8323,746,7334,142,7241,181,5921,078,649698,960555,403545,322765,736
   > Total Current Liabilities 
252,405
282,764
316,576
317,538
299,043
423,126
646,077
592,865
715,296
1,079,711
1,053,006
1,071,763
977,987
1,257,321
1,366,558
1,335,138
3,474,312
1,955,847
2,315,604
2,315,6041,955,8473,474,3121,335,1381,366,5581,257,321977,9871,071,7631,053,0061,079,711715,296592,865646,077423,126299,043317,538316,576282,764252,405
       Short-term Debt 
103,635
138,881
183,992
151,710
113,991
191,635
147,789
192,003
251,389
165,860
186,797
203,944
133,067
268,199
320,802
319,571
2,394,182
681,273
897,915
897,915681,2732,394,182319,571320,802268,199133,067203,944186,797165,860251,389192,003147,789191,635113,991151,710183,992138,881103,635
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,730,711
154,567
204,250
200,085
129,122
264,851
276,397
276,929
2,345,615
578,917
0
0578,9172,345,615276,929276,397264,851129,122200,085204,250154,5672,730,71100000000
       Accounts payable 
70,587
81,513
76,934
99,215
120,909
160,678
280,722
228,405
273,621
439,631
409,986
461,073
423,096
561,883
581,882
601,618
628,992
731,918
813,114
813,114731,918628,992601,618581,882561,883423,096461,073409,986439,631273,621228,405280,722160,678120,90999,21576,93481,51370,587
       Other Current Liabilities 
26,161
17,256
23,702
29,725
12,230
18,236
101,993
6,243
182,823
453,847
447,032
399,742
407,595
411,714
453,236
389,969
407,599
504,822
565,382
565,382504,822407,599389,969453,236411,714407,595399,742447,032453,847182,8236,243101,99318,23612,23029,72523,70217,25626,161
   > Long-term Liabilities 
513,331
262,558
238,827
381,422
779,606
758,466
3,496,647
3,153,868
3,018,536
4,707,150
5,247,319
5,330,031
6,308,312
6,523,121
7,330,285
7,219,583
7,612,488
11,120,586
11,152,774
11,152,77411,120,5867,612,4887,219,5837,330,2856,523,1216,308,3125,330,0315,247,3194,707,1503,018,5363,153,8683,496,647758,466779,606381,422238,827262,558513,331
       Other Liabilities 
0
0
0
0
5,078
4,599
193,272
150,365
174,266
117,127
733,572
648,935
430,134
502,613
544,198
617,483
682,364
2,051,734
0
02,051,734682,364617,483544,198502,613430,134648,935733,572117,127174,266150,365193,2724,5995,0780000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
45,000
45,262
49,019
70,620
232,345
287,205
331,808
575,515
633,240
1,622,641
0
01,622,641633,240575,515331,808287,205232,34570,62049,01945,26245,00000000000
> Total Stockholder Equity
55,826
367,944
383,185
480,029
566,371
693,040
1,662,507
1,876,768
2,101,262
2,658,123
3,296,203
3,721,481
3,629,079
4,225,554
4,822,119
5,108,392
6,096,643
6,129,938
5,827,166
5,827,1666,129,9386,096,6435,108,3924,822,1194,225,5543,629,0793,721,4813,296,2032,658,1232,101,2621,876,7681,662,507693,040566,371480,029383,185367,94455,826
   Common Stock
70,169
106,532
106,532
106,532
152,682
141,357
117,882
1,008,237
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,008,237117,882141,357152,682106,532106,532106,53270,169
   Retained Earnings 
25,556
45,394
0
0
147,972
115,513
50,307
256,686
276,796
384,309
412,530
422,548
539,714
459,895
488,318
618,546
182,803
208,279
0
0208,279182,803618,546488,318459,895539,714422,548412,530384,309276,796256,68650,307115,513147,9720045,39425,556
   Accumulated Other Comprehensive Income 
-39,899
216,018
85,940
163,054
224,650
352,871
627,074
614,905
794,134
1,312,734
1,911,916
2,337,311
2,121,455
2,790,768
3,353,053
3,503,248
5,047,697
5,053,547
4,949,582
4,949,5825,053,5475,047,6973,503,2483,353,0532,790,7682,121,4552,337,3111,911,9161,312,734794,134614,905627,074352,871224,650163,05485,940216,018-39,899
   Capital Surplus 0000000000000000000
   Treasury Stock000000-1,000,000,000,000,000-7,771,411,096-19,784,555,404,820-83,8020-4,035-2,500-2,557-9700000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,591,977
Cost of Revenue-4,269,276
Gross Profit2,322,7012,322,701
 
Operating Income (+$)
Gross Profit2,322,701
Operating Expense-1,584,785
Operating Income737,916737,916
 
Operating Expense (+$)
Research Development330,551
Selling General Administrative1,209,691
Selling And Marketing Expenses-
Operating Expense1,584,7851,540,242
 
Net Interest Income (+$)
Interest Income-
Interest Expense-633,756
Other Finance Cost-59,620
Net Interest Income-574,136
 
Pretax Income (+$)
Operating Income737,916
Net Interest Income-574,136
Other Non-Operating Income Expenses-
Income Before Tax (EBT)161,2001,314,632
EBIT - interestExpense = 104,160
102,664
693,071
Interest Expense633,756
Earnings Before Interest and Taxes (EBIT)737,916794,956
Earnings Before Interest and Taxes (EBITDA)1,179,834
 
After tax Income (+$)
Income Before Tax161,200
Tax Provision-27,215
Net Income From Continuing Ops138,294133,985
Net Income59,315
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses5,854,061
Total Other Income/Expenses Net-576,716574,136
 

Technical Analysis of Grifols
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Grifols. The general trend of Grifols is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Grifols's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Grifols SA ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.37 < 9.42 < 12.15.

The bearish price targets are: 5.3001.

Tweet this
Grifols SA ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Grifols SA ADR. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Grifols SA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Grifols SA ADR. The current macd is -0.39208143.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Grifols price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Grifols. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Grifols price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Grifols SA ADR Daily Moving Average Convergence/Divergence (MACD) ChartGrifols SA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Grifols SA ADR. The current adx is 21.68.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Grifols shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Grifols SA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Grifols SA ADR. The current sar is 7.38487831.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Grifols SA ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Grifols SA ADR. The current rsi is 47.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Grifols SA ADR Daily Relative Strength Index (RSI) ChartGrifols SA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Grifols SA ADR. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Grifols price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Grifols SA ADR Daily Stochastic Oscillator ChartGrifols SA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Grifols SA ADR. The current cci is 49.07.

Grifols SA ADR Daily Commodity Channel Index (CCI) ChartGrifols SA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Grifols SA ADR. The current cmo is 2.23915492.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Grifols SA ADR Daily Chande Momentum Oscillator (CMO) ChartGrifols SA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Grifols SA ADR. The current willr is -27.6119403.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Grifols is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Grifols SA ADR Daily Williams %R ChartGrifols SA ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Grifols SA ADR.

Grifols SA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Grifols SA ADR. The current atr is 0.49705481.

Grifols SA ADR Daily Average True Range (ATR) ChartGrifols SA ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Grifols SA ADR. The current obv is -24,645,739.

Grifols SA ADR Daily On-Balance Volume (OBV) ChartGrifols SA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Grifols SA ADR. The current mfi is 60.76.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Grifols SA ADR Daily Money Flow Index (MFI) ChartGrifols SA ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Grifols SA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Grifols SA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.079
Ma 20Greater thanMa 506.382
Ma 50Greater thanMa 1007.467
Ma 100Greater thanMa 2008.636
OpenGreater thanClose6.520
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Grifols with someone you think should read this too:
  • Are you bullish or bearish on Grifols? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Grifols? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Grifols SA ADR.

Receive notifications about Grifols SA ADR in your mailbox!